Reference | Outcome | Level of comparison | N cases/ N controls | N datasets | Effect size metric | Random-effects meta-analysis (95 % CI) | P value (random) | I2 | 95 % prediction intervals | P value for Egger test | P value for Excess significance test |
---|---|---|---|---|---|---|---|---|---|---|---|
Araujo de Franca, 2014 [59] | Waist circumference | Per 1 kg increase | 4898d | 6 | Regression coefficient | −0.10 (−0.73 to 0.53) | 0.760 | 73.2 | −2.04 to 1.84 | 0.725 | 0.943 |
Araujo de Franca, 2014 [59] | Waist-to-hip ratio | Per 1 kg increase | 5008d | 10 | Regression coefficient | −0.59 (−0.84 to −0.34) | 4.0 × 10−6 | 0 | −0.89 to −0.30 | 0.545 | 0.052 |
Baird, 2011 [48] | BMC in hip | Per 1 kg increase | 1795d | 6 | Regression coefficient | 1.42 (0.90 to 1.94) | 8.3 × 10−8 | 5.9 | 0.56 to 2.28 | 0.584 | 0.838 |
Baird, 2011 [48] | BMC in lumbar spine | Per 1 kg increase | 3181d | 7 | Regression coefficient | 1.72 (0.76 to 2.67) | 4.2 × 10−4 | 33.5 | −0.53 to 3.97 | 0.069a | 1.6 × 10−4 |
Baird, 2011 [48] | BMD in hip | Per 1 kg increase | 3188d | 7 | Regression coefficient | 0.01 (0.00 to 0.02) | 0.235 | 0 | −0.01 to 0.01 | 0.708 | 0.271 |
Baird, 2011 [48] | BMD in lumbar spine | Per 1 kg increase | 3506d | 8 | Regression coefficient | 0.00 (−0.01 to 0.01) | 0.779 | 14.9 | −0.02 to 0.02 | 0.831 | 0.341 |
Berhan, 2014 [46] | Perinatal mortality in developing countries | <2500 g vs. ≥ 2500 g | 21,184/285,970 | 14 | OR | 9.59 (6.11 to 15.04) | 7.5 × 10−23 | 98.9 | 1.43 to 64.18 | 0.954 | 0.707 |
Caughey, 2009 [13] | Acute lymphoblastic leukaemia | <2500 g vs. ≥ 2500 g | 4805/765,827 | 10 | RR | 0.97 (0.81 to 1.16) | 0.736 | 0 | 0.78 to 1.20 | 0.289 | NP |
Caughey, 2009 [13] | Acute lymphoblastic leukaemia | >4000 g vs. ≤ 4000 g | 11,082/2,228,906 | 23 | RR | 1.29 (1.17 to 1.42) | 1.9 × 10−7 | 36.3 | 0.97 to 1.72 | 0.055a | 9.4 × 10−7 |
Caughey, 2009 [13] | Acute lymphoblastic leukaemia | Per 1 kg increase | 7404/858,650 | 16 | RR | 1.19 (1.10 to 1.28) | 1.7 × 10−5 | 54.7 | 0.93 to 1.52 | 0.990 | 2.2 × 10−4 |
Caughey, 2009 [13] | All types of leukaemia | <2500 g vs. ≥ 2500 g | 5766/766,202 | 11 | RR | 1.04 (0.86 to 1.26) | 0.683 | 10 | 0.76 to 1.43 | 0.357 | NP |
Caughey, 2009 [13] | All types of leukaemia | >4000 g vs. ≤ 4000 g | NA/NA | 14 | RR | 1.42 (1.26 to 1.60) | 1.2 × 10−8 | 28.5 | 1.07 to 1.88 | 0.001a | NA |
Caughey, 2009 [13] | All types of leukaemia | Per 1 kg increase | 11,313/861,710 | 21 | RR | 1.19 (1.12 to 1.27) | 5.1 × 10−8 | 45.3 | 0.97 to 1.45 | 0.590 | 0.001 |
Caughey, 2009 [13] | Acute myeloid leukaemia | <2500 g vs. ≥ 2500 g | 756/851,204 | 9 | RR | 1.46 (0.87 to 2.43) | 0.151 | 43.7 | 0.39 to 5.43 | 0.606 | NP |
Caughey, 2009 [13] | Acute myeloid leukaemia | >4000 g vs. ≤ 4000 g | 756/851,204 | 9 | RR | 1.25 (1.09 to 1.43) | 1.3 × 10−3 | 43.9 | 0.88 to 1.77 | 0.216 | 3.1 × 10−4 |
Chen, 2012 [60] | Bone tumour | >4000 g vs. NBW | 4044/272,354 | 8 | OR | 1.21 (0.97 to 1.50) | 0.091 | 37.8 | 0.71 to 2.03 | 0.093a | 0.396 |
Christian, 2013 [40] | Childhood stunting | SGA vs. AGA (BW ≥ 2500 g) | 5413/16,663 | 10 | OR | 1.92 (1.75 to 2.12) | 1.1 × 10−41 | 0 | 1.72 to 2.15 | 0.968 | NP |
Christian, 2013 [40] | Childhood stunting | SGA vs. AGA (BW < 2500 g) | 843/1171 | 10 | OR | 3.00 (2.36 to 3.81) | 2.3 × 10−19 | 56.6 | 1.53 to 5.85 | 0.555 | NP |
Cook, 2010 [58] | Testicular cancer | <2500 g vs. NBW | 6906/612,741 | 17 | OR | 1.34 (1.08 to 1.67) | 7.9 × 10−3 | 50.9 | 0.69 to 2.62 | 0.135 | 0.049 |
Davey-Smith, 2007 [61] | Maternal cardiovascular mortality | Per 1 SD increase | 2976/974,667 | 6 | HR | 0.75 (0.67 to 0.84) | 3.1 × 10−7 | 79.8 | 0.53 to 1.06 | 0.657 | 0.119 |
Davey-Smith, 2007 [61] | Paternal cardiovascular mortality | Per 1 SD increase | 9375/774,325 | 3 | HR | 0.93 (0.91 to 0.95) | 2.0 × 10−9 | 0 | 0.80 to 1.09 | 0.317 | 0.516 |
der Voort, 2014 [8] | Pre-school wheezing | <2500 g vs. NBW | 40,603/103,271 | 26 | OR | 1.10 (1.00 to 1.21) | 0.051 | 16 | 0.89 to 1.36 | 0.829 | NP |
der Voort, 2014 [8] | School-age asthma | <2500 g vs. NBW | 11,729/121,198 | 16 | OR | 1.13 (1.01 to 1.27) | 0.032 | 0 | 1.00 to 1.28 | 0.639 | NP |
Dodds, 2012 [62] | Muscle strength | Per 1 kg increase | 20,461d | 14 | Regression coefficient | 0.86 (0.58 to 1.15) | 1.9 × 10−9 | 56.4 | −0.01 to 1.74 | 0.965 | NP |
Harder, 2007 [7] | Type 2 diabetes mellitus | <2500 g vs. ≥ 2500 g | 5815/100,759 | 10 | OR | 1.32 (1.06 to 1.64) | 0.013 | 60.8 | 0.71 to 2.43 | 0.196 | NP |
Harder, 2007 [7] | Type 2 diabetes mellitus | >4000 g vs. ≤ 4000 g | 6005/108,400 | 9 | OR | 1.27 (1.01 to 1.59) | 0.044 | 68.2 | 0.62 to 2.58 | 0.817 | NP |
Harder, 2008 [63] | Astrocytoma | <2500 g vs. ≥ 2500 g | 1574/160,146 | 6 | OR | 0.85 (0.58 to 1.25) | 0.410 | 31.1 | 0.35 to 2.09 | 0.931 | NP |
Harder, 2008 [63] | Astrocytoma | >4000 g vs. ≤ 4000 g | 1812/1,649,625 | 8 | OR | 1.38 (1.07 to 1.79) | 0.014 | 57.5 | 0.66 to 2.88 | 0.632 | 0.160 |
Harder, 2008 [63] | Medulloblastoma | <2500 g vs. ≥ 2500 g | 747/158,163 | 5 | OR | 1.65 (0.42 to 6.50) | 0.475 | 88.2 | 0.01 to 223 | 0.828a | 0.503 |
Harder, 2008 [63] | Medulloblastoma | >4000 g vs. ≤ 4000 g | 853/1,647,552 | 7 | OR | 1.28 (1.02 to 1.59) | 0.033 | 5.6 | 0.90 to 1.80 | 0.818 | NP |
Harder, 2009 [64] | Type 1 diabetes mellitus | <2500 g vs. ≥ 2500 g | 5236/1,385,809 | 8 | OR | 0.82 (0.55 to 1.24) | 0.344 | 91.4 | 0.20 to 3.31 | 0.067 | NP |
Harder, 2009 [64] | Type 1 diabetes mellitus | >4000 g vs. ≤ 4000 g | 6406/2,388,046 | 10 | OR | 1.17 (1.09 to 1.26) | 1.2 × 10−5 | 0 | 1.08 to 1.28 | 0.883 | NP |
Harder, 2010 [65] | Neuroblastoma | <2500 g vs. ≥ 2500 g | 2907/2,156,535 | 10 | OR | 1.24 (0.99 to 1.55) | 0.058 | 30.2 | 0.74 to 2.07 | 0.731 | NP |
Harder, 2010 [65] | Neuroblastoma | >4000 g vs. ≤ 4000 g | 2856/2,156,654 | 10 | OR | 1.19 (1.04 to 1.36) | 0.013 | 0 | 1.01 to 1.39 | 0.517 | NP |
Jackson 2013 [66] | Pneumonia in childhood | <2500 g vs. ≥ 2500 g | 1281/1464 | 4 | OR | 3.18 (1.02 to 9.91) | 0.046 | 95.6 | 0.01 to 714 | 0.366 | NP |
Kormos, 2013 [67] | Intelligence in adolescence | <2500 g vs. NBW | NA/NA | 15 | ORc | 0.35 (0.27 to 0.45) | 1.7 × 10−16 | 75.4 | 0.14 to 0.84 | 0.001a | 7.8 × 10−4 |
Lawlor 2005 [68] | FEV1 | Per 1 kg increase | 5438d | 7 | Regression coefficient | 0.06 (0.03 to 0.08) | 1.4 × 10−5 | 36.5 | −0.01 to 0.12 | 0.242 | NP |
Lawlor 2006 [69] | Total cholesterol in men | Per 1 kg increase | 33,650d | 34 | Regression coefficient | −0.04 (−0.07 to −0.01) | 0.018 | 49.8 | −0.15 to 0.07 | 0.377 | NP |
Lawlor 2006 [69] | Total cholesterol in women | Per 1 kg increase | 23,129d | 34 | Regression coefficient | −0.01 (−0.04 to 0.02) | 0.510 | 27.7 | −0.09 to 0.07 | 0.686 | NP |
Loret de Mola, 2014 [55] | Depression in adulthood | SGA vs. AGA | 397/2844 | 5 | OR | 1.14 (0.64 to 2.03) | 0.656 | 49.3 | 0.20 to 6.36 | 0.791 | NP |
Mebrahtu, 2015 [11] | Wheezing disorders in childhood | <2500 g vs. ≥ 2500 g | 145,421/665,431 | 20 | OR | 1.61 (1.39 to 1.85) | 1.1 × 10−10 | 82.3 | 0.92 to 2.80 | 0.021a | NP |
Mebrahtu, 2015 [11] | Wheezing disorders in childhood | >4000 g vs. NBW | 44,988/736,940 | 10 | OR | 1.02 (1.00 to 1.05) | 0.100 | 0 | 0.99 to 1.05 | 0.985 | NP |
Michos, 2007 [70] | Testicular cancer | >4000 g vs. NBW | 5684/123,120 | 10 | OR | 1.14 (0.99 to 1.31) | 0.075 | 42.8 | 0.80 to 1.62 | 0.791 | 0.006 |
Milne, 2013 [56] | Acute lymphoblastic leukaemia | SGA vs. AGA | 6835/11,689 | 12 | OR | 1.24 (1.13 to 1.36) | 4.9 × 10−6 | 0 | 1.12 to 1.37 | 0.101 | NP |
Mu, 2012 [71] | Diastolic blood pressure | <2500 g vs. ≥ 2500 g | 29,192d | 15 | ORc | 4.45 (1.32 to 14.99) | 0.016 | 99.3 | 0.02 to 902 | 0.085a | 0.001 |
Mu, 2012 [71] | Systolic blood pressure | <2500 g vs. ≥ 2500 g | 32,351d | 19 | ORc | 7.45 (2.19 to 25.33) | 1.3 × 10−3 | 99.4 | 0.02 to 2296 | 0.148 | 0.615 |
Mu, 2014 [41]b | Asthma in adulthood | <2500 g vs. ≥ 2500 g | 2111/37,409 | 4 | OR | 1.25 (1.12 to 1.40) | 7.7 × 10−5 | 0 | 0.98 to 1.60 | 0.884 | NP |
Øglund, 2015 [72] | Physical activity | Per 1 kg increase | 10,667d | 8 | Regression coefficient | −3.08 (−10.20 to 4.04) | 0.397 | 9 | −14.81 to 8.66 | 0.881 | NP |
Papadopoulou, 2012 [73] | Hodgkin lymphoma in childhood | <2500 g vs. NBW | 669/64,058 | 3 | OR | 0.94 (0.54 to 1.65) | 0.829 | 0 | 0.03 to 35.25 | 0.344 | NP |
Papadopoulou, 2012 [73] | Non-Hodgkin lymphoma in childhood | <2500 g vs. NBW | 1571/68,265 | 5 | OR | 1.07 (0.71 to 1.63) | 0.740 | 55.4 | 0.29 to 3.95 | 0.599 | NP |
Papadopoulou, 2012 [73] | Non-Hodgkin lymphoma in childhood | >4000 g vs. NBW | 1615/297,469 | 6 | OR | 1.17 (0.76 to 1.81) | 0.473 | 66.7 | 0.32 to 4.28 | 0.085a | 0.207 |
Panduru, 2013 [74] | Atopic dermatitis | <2500 g vs. NBW | 6315/100,663 | 10 | OR | 0.66 (0.48 to 0.90) | 9.1 × 10−3 | 85.6 | 0.23 to 1.87 | 0.558 | 0.412 |
Panduru, 2013 [74] | Atopic dermatitis | >4000 g vs. NBW | 6224/62,672 | 6 | OR | 1.13 (0.97 to 1.31) | 0.108 | 62.9 | 0.74 to 1.73 | 0.426 | NP |
Risnes, 2011 [42]b | All-cause mortality | <3000 g vs. NBW | 32,926/276,648 | 8 | HR | 1.12 (1.07 to 1.16) | 6.9 × 10−8 | 21.7 | 1.03 to 1.21 | 0.642 | NP |
Risnes, 2011 [42]b | All-cause mortality | >4000 g vs. NBW | 32,926/276,648 | 8 | HR | 1.02 (0.98 to 1.05) | 0.302 | 0 | 0.98 to 1.06 | 0.317 | NP |
Risnes, 2011 [42]b | All-cause mortality | Per 1 kg increase | 36,834/361,874 | 18 | HR | 0.94 (0.92 to 0.97) | 2.6 × 10−6 | 18.6 | 0.89 to 0.99 | 0.838 | 0.038 |
Risnes, 2011 [42]b | Mortality from cardiovascular diseases | Per 1 kg increase | 11,366/314,715 | 16 | HR | 0.88 (0.85 to 0.91) | 1.6 × 10−13 | 0 | 0.84 to 0.91 | 0.717 | 0.177 |
Risnes, 2011 [42]b | Mortality from cancer | Per 1 kg increase | 9233/269,944 | 10 | HR | 1.09 (1.04 to 1.14) | 3.4 × 10−4 | 20.8 | 0.99 to 1.19 | 0.276 | 0.037 |
Schellong, 2012 [43]b | Overweight/obese in adulthood | <2500 g vs. ≥ 2500 g | 73,420/330,648 | 30 | OR | 0.67 (0.59 to 0.76) | 1.1 × 10−9 | 82 | 0.38 to 1.18 | 0.079a | NP |
Schellong, 2012 [43]b | Overweight/obese in adulthood | >4000 g vs. ≤ 4000 g | 96,296/396,381 | 45 | OR | 1.68 (1.58 to 1.79) | 3.6 × 10−57 | 74.9 | 1.24 to 2.28 | 0.133 | NP |
Silveira 2008 [75] | Metabolic syndrome | <2500 g vs. NBW | NA/NA | 11 | OR | 2.54 (1.57 to 4.09) | 1.4 × 10−4 | 39.2 | 0.75 to 8.60 | 0.204 | NA |
Shi, 2015 [76] | RSV-related acute lower respiratory infection in childhood | <2500 g vs. NBW | 3383/155,872 | 5 | OR | 1.91 (1.45 to 2.53) | 5.9 × 10−6 | 59.1 | 0.81 to 4.54 | 0.881 | NP |
van Montfoort, 2005 [77] | Cortisol levels | Per 1 kg increase | 2301d | 11 | Regression coefficient | −20.49 (−35.97 to −5.00) | 9.5 × 10−3 | 46.3 | −61.37 to 20.4 | 0.524 | NP |
Wang, 2014 [9] | Coronary heart disease | <2500 g vs. ≥ 2500 g | 13,089/360,209 | 16 | OR | 1.22 (1.13 to 1.31) | 4.7 × 10−7 | 7 | 1.08 to 1.37 | 0.039a | 0.751 |
Wang, 2014 [9] | Coronary heart disease | >4000 g vs. ≤ 4000 g | 18,243/313,235 | 14 | OR | 0.89 (0.81 to 0.98) | 0.019 | 47.4 | 0.68 to 1.16 | 0.226 | NP |
Wang, 2014 [9] | Coronary heart disease | Per 1 kg increase | NA/NA | 23 | OR | 0.82 (0.78 to 0.86) | 2.4 × 10−15 | 41.1 | 0.70 to 0.96 | 0.014a | NA |
Whincup, 2008 [78] | Type 2 diabetes mellitus | Per 1 kg increase | 6090/145,994 | 31 | OR | 0.80 (0.72 to 0.88) | 1.8 × 10−5 | 66.5 | 0.52 to 1.21 | 0.286 | 0.355 |
White, 2009 [79] | Chronic kidney disease | <2500 g vs. NBW | NA/NA | 21 | OR | 1.73 (1.44 to 2.08) | 8.3 × 10−9 | 66.3 | 0.88 to 3.38 | 0.015a | NA |
Wojcik, 2013 [14]b | Depression in adulthood | <2500 g vs. ≥ 2500 g | 9013/50,428 | 18 | OR | 1.15 (1.00 to 1.32) | 0.057 | 34.3 | 0.79 to 1.67 | 0.171 | NP |
Xu, 2009 [80] | Breast cancer | Per 1 kg increase | 16,299/3,604,802 | 16 | OR | 1.08 (1.03 to 1.13) | 2.8 × 10−3 | 22.5 | 0.97 to 1.20 | 0.452 | 4.1 × 10−4 |
Yang, 2014 [12] | Colorectal cancer | Per 1 kg increase | 5985/723,087 | 5 | RR | 1.05 (0.93 to 1.19) | 0.461 | 57.1 | 0.72 to 1.52 | 0.457 | 0.149 |
Yang, 2014 [12] | Endometrial cancer | Per 1 kg increase | 3780/671,410 | 5 | RR | 0.91 (0.81 to 1.03) | 0.128 | 40.2 | 0.65 to 1.27 | 0.867 | 0.758 |
Yang, 2014 [12] | Lung cancer | Per 1 kg increase | 5207/696,742 | 4 | RR | 1.09 (1.02 to 1.16) | 0.016 | 12.3 | 0.90 to 1.31 | 0.172 | 0.436 |
Yang, 2014 [12] | Melanoma | Per 1 kg increase | 4000/3,821,122 | 6 | RR | 1.14 (1.05 to 1.24) | 1.9 × 10−3 | 0 | 1.01 to 1.29 | 0.912 | NP |
Yang, 2014 [12] | Non-Hodgkin lymphoma | Per 1 kg increase | 2056/626,082 | 3 | RR | 1.12 (1.01 to 1.24) | 0.033 | 0 | 0.58 to 2.15 | 0.487 | NP |
Yang, 2014 [12] | Ovarian cancer | Per 1 kg increase | 2880/805,887 | 5 | RR | 0.96 (0.88 to 1.04) | 0.295 | 0 | 0.83 to 1.10 | 0.609 | NP |
Zhang, 2013 [81] | Diastolic blood pressure | >4000 g vs. NBW | 150,980d | 23 | MD | 0.19 (−0.23 to 0.62) | 0.367 | 72.5 | −1.39 to 1.79 | 0.792 | NP |
Zhang, 2013 [81] | Systolic blood pressure | >4000 g vs. NBW | 151,935d | 24 | MD | −0.25 (−0.92 to 0.42) | 0.466 | 79.3 | −2.97 to 2.47 | 0.477 | NP |